GEORGE R BLUMENSCHEIN to Lymphatic Metastasis
This is a "connection" page, showing publications GEORGE R BLUMENSCHEIN has written about Lymphatic Metastasis.
Connection Strength
0.095
-
Phase II trial of single-agent foretinib (GSK1363089) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Invest New Drugs. 2013 Apr; 31(2):417-24.
Score: 0.053
-
Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid. Int J Dermatol. 2008 Mar; 47(3):276-9.
Score: 0.010
-
Significance of drug dose, timing and radiotherapy in adjuvant therapy of breast cancer. Recent Results Cancer Res. 1984; 96:141-7.
Score: 0.007
-
FAC + BCG as adjuvant therapy in breast cancer: an 8-year update. Recent Results Cancer Res. 1984; 96:129-32.
Score: 0.007
-
Multivariate analysis of prognostic factors in metastatic breast cancer. J Clin Oncol. 1983 Dec; 1(12):776-86.
Score: 0.007
-
Merkel cell carcinoma of the eyelid with a positive sentinel node. Arch Ophthalmol. 2002 May; 120(5):646-8.
Score: 0.006
-
Management of inflammatory carcinoma of the breast. A combined modality approach. Am J Clin Oncol. 1985 Apr; 8(2):134-41.
Score: 0.002
-
Male breast cancer: a natural history study. Cancer. 1979 Aug; 44(2):748-54.
Score: 0.001
-
Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED). J Surg Oncol. 1979; 12(1):27-40.
Score: 0.001